Blog
NuStar to Participate in the Barclays Select Series: Midstream & Infrastructure Corporate Access Days
NuStar Energy L.P. (NYSE: NS) announced today that Brad Barron, President and Chief Executive Officer; Danny Oliver, Executive Vice President of Business Development & Engineering; Amy Perry
NuStar Energy L.P.’s 2019 Schedule K-1 Tax Packages Now Available
NuStar Energy L.P. (NYSE: NS) today announced that the 2019 tax packages, which include the Schedule K-1’s for Series A, Series B and Series C preferred units and common units, are available online
El Paso Electric Announces Quarterly Dividend
The Board of Directors of El Paso Electric Company (NYSE:EE) has declared a regular quarterly cash dividend on its common stock of $0.385 per share. The dividend was declared on February 28, 2020
Groupon to Participate in the UBS Global Consumer and Retail Conference
Groupon, Inc. (NASDAQ: GRPN), a global leader in local commerce, today announced that Rich Williams, Chief Executive Officer, and Melissa Thomas, Chief Financial Officer, will attend the UBS Global
Western Union to Present at the Wolfe Research FinTech Forum
The Western Union Company (NYSE: WU), a global leader in cross-border, cross-currency money movement and payments, today announced that the Company will present at the Wolfe Research FinTech Forum
Nutrien Files 2019 Annual Disclosures
Nutrien Ltd. (Nutrien) (NYSE, TSX: NTR) today announced that its 2019 Annual Report, including Management’s Discussion and Analysis and Audited Consolidated Financial Statements, as well as its
Aptorum Group Announces Closing of $10 Million Registered Direct Offering of Class A Ordinary Shares and Warrants
Aptorum Group Limited (NASDAQ:APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, today announced the closing
United Bankshares, Inc. to Present at Raymond James 41st Annual Institutional Investors Conference
United Bankshares, Inc. (NASDAQ: UBSI), will be presenting at the Raymond James 41st Annual Institutional Investors Conference on Tuesday, March 3, 2020 at 8:05 a.m. (Eastern), at the JW Marriott
Berman Tabacco Files Securities Class Action Lawsuit Against Sterling Bancorp, Inc. (SBT)
On February 26, 2020, Berman Tabacco (www.bermantabacco.com), a national law firm representing investors, filed a class action lawsuit for violations of the federal securities laws against Sterling
Nanobiotix 2019 Q4 and Annual Revenues
Regulatory News:
NANOBIOTIX (Paris:NANO) (Euronext : NANO – ISIN : FR0011341205 – the ‘‘Company’’), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of
Insight Honors Companies Successfully Transforming Through Tech at Evolve 2020 Event
Insight Enterprises (NASDAQ:NSIT), the global integrator of Insight Intelligent Technology Solutions™ for organizations of all sizes, honored companies that are achieving success through digital
Craft Brew Alliance to Report Fourth Quarter and Full-Year 2019 Financial Results on March 11, 2020
Craft Brew Alliance, Inc. (“CBA”) (Nasdaq: BREW), a leading craft brewing company, today announced it will report fourth quarter and full-year 2019 financial results on Wednesday, March 11, 2020
Michelle M. MacKay Will Join Cushman & Wakefield as Chief Operating Officer
Cushman & Wakefield (NYSE: CWK) announced today that Michelle M. MacKay will join the firm as Chief Operating Officer (COO), stepping down from her role on the firm’s Board of Directors, effective
AgeX Therapeutics Researchers Publish Paper on the Age Reprogramming of Super-Centenarian Cells
AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company focused on developing therapeutics for human aging and regeneration, announced a new paper co-authored by two AgeX
Puma Biotechnology to Present at Cowen’s Annual Health Care Conference
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of
Agilent Technologies Announces Webcasts for Investment Community
Agilent Technologies Inc. (NYSE: A) today announced the following webcasts for the investment community.
40th Annual Cowen And Company Healthcare Conference
Tuesday, March 3, 2020 at 10:00 a.m
Antibe Therapeutics Announces Enrollment of Last Patient in Phase 2B Dose-ranging, Efficacy Study of Lead Drug, ATB-346
Antibe Therapeutics Inc. ("Antibe" or the “Company”) (TSXV: ATE, OTCQB: ATBPF), a leader in developing safer, non-addictive therapeutics for pain and inflammation, is pleased to announce that the
Sangamo Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
Sangamo Therapeutics, Inc. (NASDAQ: SGMO), a genomic medicine company, today reported fourth quarter and full year 2019 financial results and recent business highlights.
“This quarter marked an
Marko Maras, CEO of Audiens accepted into Forbes Business Council
Marko Maras, CEO of Audiens, a global customer data platform that gives marketers an easy to use audience creation platform, has been accepted into the Forbes Business Council, the foremost growth
Fluidra Achieves Its Objectives in the First Full Year After the Merger With Zodiac
Fluidra closed 2019, the first full year after the merger, with growth across all main business indicators. The global leader in the pool and wellness equipment business closed 2019 with an
Notice of ABB’s Annual General Meeting on March 26, 2020
ABB today published the invitation to its Annual General Meeting (AGM), which will be held on Thursday, March 26, 2020. The invitation can be found on ABB’s investor relations website at www.abb.co
Helmerich & Payne, Inc. to Participate in the Credit Suisse 25th Annual Energy Summit In Vail, Colorado
Helmerich & Payne, Inc. (NYSE: HP) today announced that Mark Smith, Senior Vice President and CFO; John Bell, Vice President of International & Offshore Operations; and Dave Wilson, Director of
Biogen and Sangamo Announce Global Collaboration to Develop Gene Regulation Therapies for Alzheimer’s, Parkinson’s, Neuromuscular, and Other Neurological Diseases
Biogen Inc. (Nasdaq: BIIB) and Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that they have executed a global licensing collaboration agreement to develop
James Quincey Elected to Pfizer’s Board of Directors
Pfizer Inc. (NYSE: PFE) today announced the election of James Quincey to its Board of Directors, effective immediately. Mr. Quincey, age 55, was also appointed to the Compensation Committee and the